Structures by: Yusof N. M.
Total: 5
4,4-Dimethyl-4,5-dihydro-1H-1,5-benzodiazepin-2(3H)-one
C11H14N2O
Acta Crystallographica Section E (2006) 62, 12 o5887-o5888
a=9.355(3)Å b=10.335(3)Å c=10.781(3)Å
α=90.00° β=91.106(6)° γ=90.00°
1-(4-Methylphenylsulfonyl)-5-nitro-2-[(E)-prop-1-enyl]-1H-benzimidazole
C17H15N3O4S
Acta Crystallographica Section E (2006) 62, 12 o5455-o5456
a=7.421(2)Å b=9.629(2)Å c=13.144(4)Å
α=68.962(5)° β=85.274(4)° γ=71.978(5)°
1-(4-Methylphenylsulfonyl)-5-nitro-1H-benzimidazole
C14H11N3O4S
Acta Crystallographica Section E (2007) 63, 1 o323-o324
a=10.630(3)Å b=9.950(3)Å c=13.662(4)Å
α=90.00° β=104.577(4)° γ=90.00°
2-(4-Bromophenyl)-1H-benzimidazole
C13H9BrN2
Acta Crystallographica Section E (2007) 63, 3 o1260-o1261
a=9.3969(17)Å b=9.7876(18)Å c=23.982(4)Å
α=90.00° β=90.00° γ=90.00°
2-(4-Fluorophenyl)-1H-benzimidazole
C13H9FN2
Acta Crystallographica Section E (2007) 63, 3 o1402-o1403
a=8.574(2)Å b=9.830(3)Å c=24.680(7)Å
α=90.00° β=90.00° γ=90.00°